4.6 Review

Aptamer-Based Diagnostic Systems for the Rapid Screening of TB at the Point-of-Care

Journal

DIAGNOSTICS
Volume 11, Issue 8, Pages -

Publisher

MDPI
DOI: 10.3390/diagnostics11081352

Keywords

tuberculosis; aptamers; diagnostics; lateral flow assays; point-of-care; biomarkers

Funding

  1. DSI/Mintek NIC Biolabels Node at UWC

Ask authors/readers for more resources

The transmission of Tuberculosis is rapid and impacts healthcare systems globally. Current diagnostic methods are time-consuming and costly. By utilizing aptamers instead of antibodies, new rapid tests can be developed that are more cost-effective, stable, and reliable.
The transmission of Tuberculosis (TB) is very rapid and the burden it places on health care systems is felt globally. The effective management and prevention of this disease requires that it is detected early. Current TB diagnostic approaches, such as the culture, sputum smear, skin tuberculin, and molecular tests are time-consuming, and some are unaffordable for low-income countries. Rapid tests for disease biomarker detection are mostly based on immunological assays that use antibodies which are costly to produce, have low sensitivity and stability. Aptamers can replace antibodies in these diagnostic tests for the development of new rapid tests that are more cost effective; more stable at high temperatures and therefore have a better shelf life; do not have batch-to-batch variations, and thus more consistently bind to a specific target with similar or higher specificity and selectivity and are therefore more reliable. Advancements in TB research, in particular the application of proteomics to identify TB specific biomarkers, led to the identification of a number of biomarker proteins, that can be used to develop aptamer-based diagnostic assays able to screen individuals at the point-of-care (POC) more efficiently in resource-limited settings.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available